UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035302
Receipt number R000039850
Scientific Title Effect of oxytocin nasal spray on auditory automatic discrimination measured by mismatch negativity in schizophrenia
Date of disclosure of the study information 2018/12/19
Last modified on 2019/06/24 15:18:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of oxytocin nasal spray on auditory automatic discrimination measured by mismatch negativity in schizophrenia

Acronym

Effect of oxytocin nasal spray on auditory automatic discrimination measured by mismatch negativity

Scientific Title

Effect of oxytocin nasal spray on auditory automatic discrimination measured by mismatch negativity in schizophrenia

Scientific Title:Acronym

Effect of oxytocin nasal spray on auditory automatic discrimination measured by mismatch negativity

Region

Japan


Condition

Condition

schizophrenia

Classification by specialty

Psychiatry Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

For treating progressively cognitive dysfunction in schizophrenia, oxytocin nasal sprays are thought to improve social cognition, facial expression recognition, and smell identification ability. MMN is thought to acutely reflect cognitive dysfunction in schizophrenia. The purpose of this study is to clarify the effect on auditory cognitive function by oxytocin and to apply MMN to social function assessment of schizophrenia.
In this study, it is to clarify whether the effect of treatment of oxytocin nasal spray improve MMN and identify MMN paradigm that is sensitive to cognitive function assessment of schizophrenia.

Basic objectives2

Pharmacodynamics

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Mismatch negativity(MMN)

Key secondary outcomes

Facial Emotion Selection Test(FEST)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Single administration of 24 IU of oxytocin nasal sprays to schizophrenia.

Interventions/Control_2

Single administration of 24 IU of placebo nasal sprays to schizophrenia.

Interventions/Control_3

Single administration of 24 IU of oxytocin nasal sprays to healthy subjects.

Interventions/Control_4

Single administration of 24 IU of placebo nasal sprays to healthy subjects.

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients were diagnosed Schizophrenia in DSM-5 (Diagnostic and Statistical Manual of Mental Disorders), which was thought to be able to fully understand the contents of the experiment and its significance.

Key exclusion criteria

Exclusion criteria were epilepsy, mental retardation, a history of hypersensitivity to Oxytocin, drug abuse / dependence, continuous administration of Oxytocin, pregnancy, and a history of psychiatric or neurological disorders.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Ochiai
Middle name
Last name Haruka

Organization

Fukushima Medical University

Division name

Department of Psychiatry

Zip code

9601247

Address

1, Hikarigaoka, Fukushima-shi, Fukushima

TEL

0245471331

Email

haruka-o@fmu.ac.jp


Public contact

Name of contact person

1st name Ochiai
Middle name
Last name Haruka

Organization

Fukushima Medical University

Division name

Department of Psychiatry

Zip code

9601247

Address

1, Hikarigaoka, Fukushima-shi, Fukushima

TEL

0245471331

Homepage URL


Email

haruka-o@fmu.ac.jp


Sponsor or person

Institute

Fukushima Medical University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fukushima Medical University Medical Research Promotion Division Clinical Research Review Committee Secretariat

Address

1, Hikarigaoka, Fukushima-shi, Fukushima

Tel

0245471825

Email

rs@fmu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 12 Month 19 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled

66

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 02 Month 01 Day

Date of IRB

2016 Year 06 Month 08 Day

Anticipated trial start date

2016 Year 06 Month 08 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 12 Month 18 Day

Last modified on

2019 Year 06 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039850


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name